All News

AI may improve symptom management, patient education and workflows in cancer care, but nurses remain essential.

Learn the risk factors, symptoms and screening options tied to colorectal cancer as cases continue rising among younger adults.

A survivor shares why advocating for a mammogram past age 75 led to a crucial second diagnosis and why family history means staying vigilant for life.

New research suggests biologic aging and neighborhood-related stress may affect how aerobic exercise influences cognition after breast cancer treatment.

Talking about what matters most with your nurses can improve your care and comfort during intensive treatments like stem cell transplants.

Patients receiving immunotherapy may develop lifelong endocrine adverse effects requiring insulin, hormone therapy and ongoing support.

A moving journey through breast cancer, discovering that vulnerability is courage and a diagnosis doesn't have to define your spirit or faith.

New research shows maintaining physical function and nutrition may help patients with advanced liver cancer stay on treatment longer and live longer.

The FDA approved Enhertu for certain patients with HER2-positive early-stage breast cancer before and after surgery based on DESTINY trial data.

The FDA approved Tecentriq for patients with muscle-invasive bladder cancer who still have detectable signs of tumor DNA in their blood after surgery.

My experience with cancer has affected the way I think about the health of my pets. Whereas the old me was more fatalistic, the survivor in me would go an extra mile to save a beloved creature.

New research suggests gut bacteria may play a role in fatigue and pain experienced by melanoma patients receiving immunotherapy.

New research shows that lymphoma survivors often face long-term peripheral neuropathy, which may be more severe than what doctors typically report.

Patients should be mindful of preserving muscle mass while receiving GLP-1 therapy during cancer treatment. Experts discuss body composition, sarcopenia and treatment durability in oncology care.

No one can face fear, pain, uncertainty, and isolation of any type of cancer alone.

Jill Winther earned CURE’s 2026 Extraordinary Healer® Award for her leadership, advocacy and dedication to oncology nursing.

FDA approves oral Inqovi plus Venclexta for newly diagnosed AML in older adults or those with comorbidities, expanding non-intensive options.

Researchers at Moffitt Cancer Center are studying DYV800, a topical cream designed to reduce tumor acidity and help the immune system fight cancer.

FDA grants accelerated approval to Beqalzi (sonrotoclax) for relapsed or refractory mantle cell lymphoma in adults after prior therapies

ctDNA liquid biopsies detect breast cancer at molecular levels to guide personalized therapy and monitor for recurrence or progression.

Dr. Susan MacDonald breaks down the TNM staging system (Tumor, Nodes, Metastasis) to help patients understand their clinical diagnosis.

A USC study finds immunotherapy increases PAD risk by 60%. Experts advise vascular monitoring to help prevent limb loss in cancer survivors.

Experts urge caution with ctDNA testing in early-stage breast cancer, citing "molecular anxiety" and a lack of clear clinical data on survival outcomes.

Oncology dietitians shared smoothie and turmeric latte recipes to help patients with breast cancer manage nutrition during treatment.

MD Anderson’s trial uses psilocybin and psychotherapy to treat cancer-related anxiety, helping patients thrive through neuroplasticity.

Learn about the FDA approval of Veppanu, the first PROTAC for ER+/HER2- metastatic breast cancer with ESR1 mutations.

A cancer survivor reflects on the profound power of physician communication, highlighting how words can either validate hope or deepen patient pain.

Learn about superficial spreading melanoma, from the ABCDE diagnostic rules to the latest in immunotherapy, targeted care and surgical options.